food and dietary supplement labeling purposes, the amount in a serving is expressed as a "percent of daily value" (%DV)
Treatment areas include: Overall countenance (treating acne scars, facial lines, creases, large pores, age spots, and uneven skin tone) Lips (treating smokers lines) Eyes (treating saggy eyelid skin and wrinkles) Coolsculpting Non Invasive Procedure Coolsculpting is a non-invasive procedure designed to transform the body by restoring its natural beauty through fat reduction
Preclinical studies showed no overt toxicity at research doses
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
People and mice differ in metabolism, body size, route exposure, and disease biology, so animal results cannot predict a person's outcome
